TransMedics Group Inc. (TMDX)
NASDAQ · Healthcare
TransMedics Group Inc. Shareholder Equity 2018–2025
TransMedics Group Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- TransMedics Group Inc. shareholder equity as of December 31, 2025: 473.1M, a 106.95% increase year-over-year.
- TransMedics Group Inc. shareholder equity for 2025 were 473.1M, a 106.95% increase from 2024.
- TransMedics Group Inc. shareholder equity for 2024 were 228.6M, a 66.62% increase from 2023.
- TransMedics Group Inc. shareholder equity for 2023 were 137.2M, a 26.78% decrease from 2022.
- TransMedics Group Inc. shareholder equity for 2022 were 187.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| TransMedics Group Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $473 |
| 2024 | $229 |
| 2023 | $137 |
| 2022 | $187 |
| 2021 | $68 |
| 2020 | $104 |
| 2019 | $55 |
| 2018 | $-192 |
TransMedics Group Inc. Shareholder Equity — FAQ
TransMedics Group Inc. (TMDX) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TMDX's shareholder equity history?
The chart and table above show TransMedics Group Inc.'s shareholder equity by year and by quarter, including the growth rate.